In 2019, the pharmaceutical sector spent $83 billion on research and development in the US alone. These costs were incurred on a range of activities, including development innovations such as product enhancements, the discovery and testing of novel medicines, and clinical trials for marketing or safety monitoring. After accounting for the effects of inflation, this sum is about ten times the annual expenditure of the sector in the 1980s.